このエントリーをはてなブックマークに追加
ID 61261
FullText URL
Author
Hamada, Kenta Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Kanzaki, Hiromitsu Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences ORCID publons researchmap
Inoue, Masafumi Department of Gastroenterology, Japanese Red Cross Okayama Hospital
Ishiyama , Shuhei Department of Internal Medicine, Okayama Saiseikai General Hospital
Yamauchi, Kenji Department of Gastroenterology, Mitoyo General Hospital
Miyahara, Koji Department of Internal Medicine, Hiroshima City Hospital
Toyokawa, Tatsuya Department of Gastroenterology, National Hospital Organization Fukuyama Medical Center
Tsuzuki, Takao Department of Internal Medicine, Japanese Red Cross Society Himeji Hospital
Miyaike, Jiro Department of Internal Medicine, Saiseikai Imabari Hospital
Matsubara, Minoru Department of Internal Medicine, Sumitomo Besshi Hospital
Takahashi, Sakuma Department of Gastroenterology, Kagawa Prefectural Central Hospital
Nishimura, Mamoru Department of Internal Medicine, Okayama City Hospital
Takenaka, Ryuta Department of Internal Medicine, Tsuyama Chuo Hospital
Yunoki, Naoko Department of Internal Medicine, Akaiwa Medical Association Hospital
Hori, Shinichiro Department of Endoscopy, National Hospital Organization Shikoku Cancer Center
Kobayashi, Sayo Department of Internal Medicine, Fukuyama City Hospital
Yamasaki, Yasushi Department of Endoscopy, Okayama University Hospital ORCID Kaken ID publons
Kawahara, Yoshiro Department of Endoscopy, Okayama University Hospital
Ishikawa, Hideki Department of Molecular-Targeting Cancer Prevention, Kyoto Prefectural University of Medicine
Okada, Hiroyuki Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Kaken ID publons researchmap
Abstract
Objective Gastric endoscopic submucosal dissection (ESD) under heparin replacement (HR) of warfarin reportedly has a high risk of delayed bleeding (24-57%). It is possible that the delayed bleeding risk may have changed over the years. We evaluated the current risk of delayed bleeding after gastric ESD under HR of anticoagulant agents.
Methods We retrospectively reviewed the delayed bleeding rate and analyzed the risk factors for delayed bleeding.
Patients Consecutive patients who underwent gastric ESD under HR of anticoagulant agents from July 2015 to June 2017.
Results A total of 32 patients with a solitary early gastric cancer and taking anticoagulant agents were analyzed, including 24 patients on warfarin (the warfarin group) and 8 patients on direct oral anticoagulants (the DOAC group). Three (9.4%) patients experienced delayed bleeding: three (12.5%) patients in the warfarin group and no patients in the DOAC group. Continued aspirin treatment was identified to be a risk factor of delayed bleeding (p=0.01).
Conclusion Careful management may be required for patients undergoing gastric ESD under continued aspirin treatment in addition to HR of anticoagulant agents; although the delayed bleeding risk after gastric ESD under HR of anticoagulant agents might have decreased over the years.
Keywords
anticoagulant agent
bleeding
endoscopic submucosal dissection
gastric cancer
heparin replacement
warfarin
Published Date
2020-11-01
Publication Title
Internal Medicine
Volume
volume59
Issue
issue21
Publisher
The Japanese Society of Internal Medicine
Start Page
2643
End Page
2651
ISSN
0918-2918
NCID
AA10827774
Content Type
Journal Article
language
English
OAI-PMH Set
岡山大学
Copyright Holders
© 2020 by The Japanese Society of Internal Medicine
File Version
publisher
PubMed ID
DOI
Web of Science KeyUT
Related Url
isVersionOf https://doi.org/10.2169/internalmedicine.4998-20
License
https://creativecommons.org/licenses/by-nc-nd/4.0/